EGFR and non-small cell lung carcinoma: A meta-analysis involving 363 NSCLC patients with EGFR mutations and BMs to compare the efficacy between upfront cranial radiotherapy and TKI alone found that upfront radiotherapy improved four-month iPFS and two-year overall survival (OS) [12].